SRFP093: Strengthening the bridge across primary and specialty care for patients with rare diseases

Melanie Langelier, MSc, RN, Doctoral Student; Peter Nugus, PhD, BA, MA, MEd

Abstract

CONTEXT: Because primary health care is the frontline of the health system, and gateway to specialized services, specialty physicians rely on family physicians to recognize rare diseases. Collaborative care demands that specialty physicians be specific in terms of the information they require from family physicians that would help them fulfill their specialized role if an optimal continuum of care is to be maintained for patients with rare diseases. Very few studies have examined the important interface between primary and acute, hospital-based care in terms of the intense case study of rare diseases, much less how cross-sector education can be optimized.
OBJECTIVE: 1, To identify the implied disease interpretations of specialty-hospital-based physicians in relation to rare diseases, and their informational expectations of family physicians for clinical decision-making. 2. To compile recommendations for feedback that will form the basis of an educational intervention for family physicians in the diagnosis and care of patients with rare diseases.
STUDY DESIGN: This study follows a qualitative research design to inductively discern perspectives, meanings and interpretations. Semi-structured interviews and observations will be undertaken. Transcripts will be analyzed through thematic analysis, whereby codes of perceptions and behaviours will be compared and contrasted, and variations accounted for.
SETTING: The setting is a quaternary care metropolitan teaching hospital, to maximize specialization and complexity as a setting to analyze decision-making.
POPULATION STUDIED: The research is being conducted among doctors at different levels of training and medical students. There is representation among different medical specialties to obtain broad representation. Participants vary by gender.
ANTICIPATED RESULTS: The research will show how valid contemporary understandings of “rare disease” are, and what constitutes optimal collaborative decision-making between care and specialty care.
CONCLUSIONS: Through the study of the intense case of rare diseases, this research will inform particular educational interventions to optimize the transfer of information, and alignment of decision-making principles across primary and acute care.
Leave a Comment
Jack Westfall
jwestfall@aafp.org 11/21/2021

Very interesting research. Great work. Thanks

Lauren Oshman
laoshman@med.umich.edu 11/22/2021

Very interesting! I always wonder how rare diseases have changed since I trained 20 years ago!

Diane Harper
harperdi@med.umich.edu 11/22/2021

Present your results in Phoenix next year! Thank you for sharing your work with NAPCRG!

William R. Phillips
wphllps@uw.edu 11/23/2021

Great idea for important work. The role of primary care physicians in the identification and care of patients with rare conditions is very interested and – as you say – rarely studied. See a landmark paper on this topic below and a follow up discussion. Family doctors in GPs often develop relatively sophisticated knowledge about the rare diseases that occur in the patients within their practice. There’s another important expert in the equation  -the patient - who becomes the special expert io their own rare disease. Both become advocates for the patient within the healthcare system. I suggest you establish a tighter focus on your research question that will lead a more manageable and fruitful study design. Does your research question start with the primary care, specialist or patient experience and perspective? Are we studying the roles of PC and specialists in patient care, communication patterns between them, long-term contributions to patient care, etc.  Communication and education should follow description and evidence.  I would suggest that the information needs for the specialist is the least of the concerns in this trajectory of patient care. More important is the specialist understanding of the information needs of the family Doctor, who will assume some  role - often a major role in the ongoing care of the patient. I think studying student and early trainees will not be very informative, as they have had little experience with rare diseases and likely none of it in primary care settings.  Also, be aware that this research space is distorted by big Pharma companies whose agenda is to increase the identification of patients that might use exorbitantly expensive treatments. Good luck with this interesting study. It could turn into a long program of valuable research. – Bill Phillips Phillips WR. Zebras on the commons: rare conditions in family practice. J Am Board Fam Pract. 2004 Jul-Aug;17(4):283-6. doi: 10.3122/jabfm.17.4.283. PMID: 15243016. Phillips WR. Innovative approaches to studying health outcomes in rare diseases. J Gen Intern Med. 2015 Jan;30(1):8. doi: 10.1007/s11606-014-3068-6. PMID: 25332059; PMCID: PMC4284266.

Andy Pasternak
avpiv711@sbcglobal.net 11/28/2021

Rare diseases are often where primary care docs often get overlooked. In some instances, we have the best knowledge base to help our patients. I'll be interested to hear your findings in PHX

Social Media

Address

NAPCRG
11400 Tomahawk Creek Parkway
Leawood, KS 66211
800.274.7928
Email: napcrgoffice@napcrg.org